Increased proportions of HIV-infected women met cervical cancer screening guideline in 2016.

about

Increased proportions of HIV-infected women met cervical cancer screening guideline in 2016.

Item

http://www.wikidata.org/entity/Q54263622

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Increased proportions of HIV-i ...... r screening guideline in 2016.

@en

Increased proportions of HIV-i ...... r screening guideline in 2016.

@nl

type

Item

label

Increased proportions of HIV-i ...... r screening guideline in 2016.

@en

Increased proportions of HIV-i ...... r screening guideline in 2016.

@nl

prefLabel

Increased proportions of HIV-i ...... r screening guideline in 2016.

@en

Increased proportions of HIV-i ...... r screening guideline in 2016.

@nl

P1476

Increased proportions of HIV-i ...... r screening guideline in 2016.

@en

P2093

Debbie Y Mohammed

http://www.w3.org/2001/XMLSchema#string

Jihad Slim

http://www.w3.org/2001/XMLSchema#string

Prerak Shukla

http://www.w3.org/2001/XMLSchema#string

Raymund Sison

http://www.w3.org/2001/XMLSchema#string

Yuriy Babayants

http://www.w3.org/2001/XMLSchema#string

P2860

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States

Perceptions of barriers and facilitators to cervical cancer screening among low-income, HIV-infected women from an integrated HIV clinic.

Risk factors for nonadherence with Pap testing in HIV-infected women.

Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.

Clinical validation of the Cervista HPV HR test according to the international guidelines for human papillomavirus test requirements for cervical cancer screening.

Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection

Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.

Cancer Screening Test Use - United States, 2015.

Cervista HPV HR test for cervical cancer screening: a comparative study in the Catalonian population.

P304

83-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJWH.S153003

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29497336

http://www.w3.org/2001/XMLSchema#string

P932

5818846

http://www.w3.org/2001/XMLSchema#string